Jennifer Karlin, Tammy Bennett, Leah Michael, Sally Rafie, Elise D Berlan
{"title":"一个系统的比较实施策略在三个美国诊所设置,扩大获得自我管理注射避孕。","authors":"Jennifer Karlin, Tammy Bennett, Leah Michael, Sally Rafie, Elise D Berlan","doi":"10.1016/j.contraception.2025.110972","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To describe experiences and systematically compare three U.S. clinics that initiated or expanded access to DMPA-SC for self-administration during the COVID-19 pandemic.</p><p><strong>Study design: </strong>We used the Expert Recommendations for Implementing Change (ERIC) framework to systematically compare three case studies of implementation projects that expanded use of self-administered DMPA-SC in the United States during the COVID-19 pandemic.</p><p><strong>Results: </strong>All three settings used multiple implementation strategies and common strategies fell into five main categories including 1) increasing provider awareness about self-administration of DMPA-SC and continuing education for clinical staff, 2) providing patient education and counseling tailored to patients' needs, 3) supporting changes in clinic workflow, 4) addressing insurance coverage and payment, and 5) reducing barriers to filling prescriptions for self-administered DMPA-SC. Ongoing implementation challenges identified include mitigating additional payment barriers for DMPA-SC and increasing access points beyond physical clinical sites.</p><p><strong>Conclusion: </strong>The implementation strategies described in this study may be generalizable to other settings and help US-based clinics and health care providers meet current recommendations for ensuring access to self-administration of DMPA-SC.</p>","PeriodicalId":93955,"journal":{"name":"Contraception","volume":" ","pages":"110972"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A systematic comparison of implementation strategies at three U.S. clinic settings that expanded access to self-administered injectable contraception.\",\"authors\":\"Jennifer Karlin, Tammy Bennett, Leah Michael, Sally Rafie, Elise D Berlan\",\"doi\":\"10.1016/j.contraception.2025.110972\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>To describe experiences and systematically compare three U.S. clinics that initiated or expanded access to DMPA-SC for self-administration during the COVID-19 pandemic.</p><p><strong>Study design: </strong>We used the Expert Recommendations for Implementing Change (ERIC) framework to systematically compare three case studies of implementation projects that expanded use of self-administered DMPA-SC in the United States during the COVID-19 pandemic.</p><p><strong>Results: </strong>All three settings used multiple implementation strategies and common strategies fell into five main categories including 1) increasing provider awareness about self-administration of DMPA-SC and continuing education for clinical staff, 2) providing patient education and counseling tailored to patients' needs, 3) supporting changes in clinic workflow, 4) addressing insurance coverage and payment, and 5) reducing barriers to filling prescriptions for self-administered DMPA-SC. Ongoing implementation challenges identified include mitigating additional payment barriers for DMPA-SC and increasing access points beyond physical clinical sites.</p><p><strong>Conclusion: </strong>The implementation strategies described in this study may be generalizable to other settings and help US-based clinics and health care providers meet current recommendations for ensuring access to self-administration of DMPA-SC.</p>\",\"PeriodicalId\":93955,\"journal\":{\"name\":\"Contraception\",\"volume\":\" \",\"pages\":\"110972\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Contraception\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.contraception.2025.110972\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contraception","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.contraception.2025.110972","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A systematic comparison of implementation strategies at three U.S. clinic settings that expanded access to self-administered injectable contraception.
Objectives: To describe experiences and systematically compare three U.S. clinics that initiated or expanded access to DMPA-SC for self-administration during the COVID-19 pandemic.
Study design: We used the Expert Recommendations for Implementing Change (ERIC) framework to systematically compare three case studies of implementation projects that expanded use of self-administered DMPA-SC in the United States during the COVID-19 pandemic.
Results: All three settings used multiple implementation strategies and common strategies fell into five main categories including 1) increasing provider awareness about self-administration of DMPA-SC and continuing education for clinical staff, 2) providing patient education and counseling tailored to patients' needs, 3) supporting changes in clinic workflow, 4) addressing insurance coverage and payment, and 5) reducing barriers to filling prescriptions for self-administered DMPA-SC. Ongoing implementation challenges identified include mitigating additional payment barriers for DMPA-SC and increasing access points beyond physical clinical sites.
Conclusion: The implementation strategies described in this study may be generalizable to other settings and help US-based clinics and health care providers meet current recommendations for ensuring access to self-administration of DMPA-SC.